Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function
- PMID: 21906802
- PMCID: PMC3190071
- DOI: 10.1016/j.biomaterials.2011.08.050
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function
Abstract
Recent advances in pluripotent stem cell research have provided investigators with potent sources of cardiogenic cells. However, tissue engineering methodologies to assemble cardiac progenitors into aligned, 3-dimensional (3D) myocardial tissues capable of physiologically relevant electrical conduction and force generation are lacking. In this study, we introduced 3D cell alignment cues in a fibrin-based hydrogel matrix to engineer highly functional cardiac tissues from genetically purified mouse embryonic stem cell-derived cardiomyocytes (CMs) and cardiovascular progenitors (CVPs). Procedures for CM and CVP derivation, purification, and functional differentiation in monolayer cultures were first optimized to yield robust intercellular coupling and maximize velocity of action potential propagation. A versatile soft-lithography technique was then applied to reproducibly fabricate engineered cardiac tissues with controllable size and 3D architecture. While purified CMs assembled into a functional 3D syncytium only when supplemented with supporting non-myocytes, purified CVPs differentiated into cardiomyocytes, smooth muscle, and endothelial cells, and autonomously supported the formation of functional cardiac tissues. After a total culture time similar to period of mouse embryonic development (21 days), the engineered cardiac tissues exhibited unprecedented levels of 3D organization and functional differentiation characteristic of native neonatal myocardium, including: 1) dense, uniformly aligned, highly differentiated and electromechanically coupled cardiomyocytes, 2) rapid action potential conduction with velocities between 22 and 25 cm/s, and 3) significant contractile forces of up to 2 mN. These results represent an important advancement in stem cell-based cardiac tissue engineering and provide the foundation for exploiting the exciting progress in pluripotent stem cell research in the future tissue engineering therapies for heart disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures





Similar articles
-
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.Biomaterials. 2013 Jul;34(23):5813-20. doi: 10.1016/j.biomaterials.2013.04.026. Epub 2013 May 2. Biomaterials. 2013. PMID: 23642535 Free PMC article.
-
Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues.Sci Rep. 2017 Feb 9;7:42290. doi: 10.1038/srep42290. Sci Rep. 2017. PMID: 28181589 Free PMC article.
-
Advances in 3D Bioprinted Cardiac Tissue Using Stem Cell-Derived Cardiomyocytes.Stem Cells Transl Med. 2024 May 14;13(5):425-435. doi: 10.1093/stcltm/szae014. Stem Cells Transl Med. 2024. PMID: 38502194 Free PMC article. Review.
-
Dynamic culture yields engineered myocardium with near-adult functional output.Biomaterials. 2016 Dec;111:66-79. doi: 10.1016/j.biomaterials.2016.09.024. Epub 2016 Sep 30. Biomaterials. 2016. PMID: 27723557 Free PMC article.
-
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.Adv Drug Deliv Rev. 2016 Jan 15;96:110-34. doi: 10.1016/j.addr.2015.04.019. Epub 2015 May 5. Adv Drug Deliv Rev. 2016. PMID: 25956564 Free PMC article. Review.
Cited by
-
Trends in cardiovascular engineering: organizing the human heart.Trends Cardiovasc Med. 2013 Nov;23(8):282-6. doi: 10.1016/j.tcm.2013.04.001. Epub 2013 May 27. Trends Cardiovasc Med. 2013. PMID: 23722092 Free PMC article. Review.
-
Organs-on-a-chip: a union of tissue engineering and microfabrication.Trends Biotechnol. 2023 Mar;41(3):410-424. doi: 10.1016/j.tibtech.2022.12.018. Epub 2023 Jan 31. Trends Biotechnol. 2023. PMID: 36725464 Free PMC article. Review.
-
Biomaterializing the promise of cardiac tissue engineering.Biotechnol Adv. 2020 Sep-Oct;42:107353. doi: 10.1016/j.biotechadv.2019.02.009. Epub 2019 Feb 20. Biotechnol Adv. 2020. PMID: 30794878 Free PMC article. Review.
-
Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.Circ Res. 2014 Jan 31;114(3):511-23. doi: 10.1161/CIRCRESAHA.114.300558. Circ Res. 2014. PMID: 24481842 Free PMC article. Review.
-
Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model.Tissue Eng Part A. 2014 Apr;20(7-8):1325-35. doi: 10.1089/ten.TEA.2013.0312. Epub 2014 Feb 6. Tissue Eng Part A. 2014. PMID: 24295499 Free PMC article.
References
-
- Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81:1161–1172. - PubMed
-
- Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920–926. - PubMed
-
- Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006;12:452–458. - PubMed
-
- Chien KR, Domian IJ, Parker KK. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science (New York, NY. 2008;322:1494–1497. - PubMed
-
- Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015–1024. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources